ARNA - Arena Pharmaceuticals Inc.

ARNA valuation $949.59 million

Stock Price

4.31
Change: ↓ -0.20 (-4.4346%)
Last Update: 2015-01-30T16:15:09-05:00
Shares Outstanding: 220,321,645
Industry: Biotechnology

Arena is embracing the challenge of improving health by seeking to bring innovative medicines targeting G protein-coupled receptors to patients.

Arena's internally discovered drug, BELVIQ (lorcaserin HCl), is approved in the United States, and Arena is focused on discovering, developing and commercializing additional drugs to address unmet medical needs.

Arena's U.S. operations are located in San Diego, California, and its operations outside of the United States, including its commercial manufacturing facility, are located in Zofingen, Switzerland.

Stock Price Data

Open: 4.66 Previous Close: 4.51
High: 4.68 Low: 4.29
Bid: 4.31 Ask: 4.32

Bid Size: 1100 Ask Size: 4400
Raw Bid Size: 11 Raw Ask Size: 44
Trade Volume: 16008 Share Volume: 6033710
Last Trade Date: 2015-01-30 Last Trade Time: 16:00:00-05:00
Vwap: 4.37563168 EPS: -0.24

Fundamental Data

PE ratio: PB ratio: 12.314
Beta: -0.583108

52 Week High: 7.36 52 Week Low: 3.26
52 Week High Vwap: 7.1373 52 Week Low Vwap: 3.3869
52 Week High Volume: 108077601 52 Week Low Volume: 1601430
52 Week Avg Volume: 5765281
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
GILD Gilead Sciences Inc. 104.83
IMGN ImmunoGen Inc. 7.63
CELG Celgene Corporation 119.10
MNKD MannKind Corporation 6.35
AMGN Amgen Inc 152.26
NVAX Novavax Inc. 7.81
NPSP NPS Pharmaceuticals Inc. 45.86
BIIB Biogen Idec Inc. 388.77
ARIA ARIAD Pharmaceuticals Inc. 6.45
PDLI PDL BioPharma Inc. 7.29